Sodium-glucose co-transporter2 expression and inflammatory activity in diabetic atherosclerotic plaques: Effects of sodium-glucose co-transporter2 inhibitor treatment

OBJECTIVE: We evaluated sodium-glucose co-transporter2 (SGLT2) expression and the effect of SGLT2 inhibitor (SGLT2i) therapies on carotid plaques of asymptomatic diabetic and non-diabetic patients. METHODS: Plaques were obtained from 296 non-diabetic patients and 227 patients with type 2 diabetes un...

Descripción completa

Detalles Bibliográficos
Autores principales: D'Onofrio, Nunzia, Sardu, Celestino, Trotta, Maria Consiglia, Scisciola, Lucia, Turriziani, Fabrizio, Ferraraccio, Franca, Panarese, Iacopo, Petrella, Lella, Fanelli, Mara, Modugno, Piero, Massetti, Massimo, Marfella, Ludovica Vittoria, Sasso, Ferdinando Carlo, Rizzo, Maria Rosaria, Barbieri, Michelangela, Furbatto, Fulvio, Minicucci, Fabio, Mauro, Ciro, Federici, Massimo, Balestrieri, Maria Luisa, Paolisso, Giuseppe, Marfella, Raffaele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473552/
https://www.ncbi.nlm.nih.gov/pubmed/34500107
http://dx.doi.org/10.1016/j.molmet.2021.101337

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473552/
https://www.ncbi.nlm.nih.gov/pubmed/34500107
http://dx.doi.org/10.1016/j.molmet.2021.101337

Ejemplares similares